Two Seas Capital LP Arbutus Biopharma Corp Transaction History
Two Seas Capital LP
- $297 Million
- Q3 2024
A detailed history of Two Seas Capital LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Two Seas Capital LP holds 8,387,388 shares of ABUS stock, worth $26.9 Million. This represents 10.86% of its overall portfolio holdings.
Number of Shares
8,387,388
Previous 8,571,751
2.15%
Holding current value
$26.9 Million
Previous $26.5 Million
21.92%
% of portfolio
10.86%
Previous 10.59%
Shares
11 transactions
Others Institutions Holding ABUS
# of Institutions
155Shares Held
99.5MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$69.7 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$41.3 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$28.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.41MShares$14.1 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $481M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...